Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By COPD Severity

被引：0
|
作者：
D'Urzo, A. [1 ]
Singh, S. D. [2 ]
Kerwin, E. M. [3 ]
Lakkis, H. [4 ]
Chuecos, F. [5 ]
De Miquel, G. [5 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Manchester, Manchester, Lancs, England
[3] Clin Res Inst, Medford, MA USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] AstraZeneca Plc, Barcelona, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5783
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
    Anthony D D’Urzo
    Stephen I Rennard
    Edward M Kerwin
    Victor Mergel
    Anne R Leselbaum
    Cynthia F Caracta
    Respiratory Research, 15
  • [32] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
    D'Urzo, Anthony D.
    Rennard, Stephen I.
    Kerwin, Edward M.
    Mergel, Victor
    Leselbaum, Anne R.
    Caracta, Cynthia F.
    RESPIRATORY RESEARCH, 2014, 15
  • [33] Dose-Ranging Study of 2 Fixed-Dose Combinations of Twice-Daily Aclidinium Bromide Plus Formoterol in Patients With Moderate to Severe COPD
    Kerwin, Edward
    Lapidus, Robert
    Leselbaum, Anne
    Ortiz, Stephan
    Rowe, Paul
    Caracta, Cynthia
    CHEST, 2013, 144 (04)
  • [34] The Effect Of Aclidinium/formoterol Fixed-Dose Combination On COPD Symptoms And Health Status In Patients With COPD: Results From The Acliform/COPD Study
    Jones, P. W.
    Singh, D.
    Bateman, E. D.
    Korn, S.
    Serra, C.
    Molins, E.
    Caracta, C.
    Leselbaum, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [35] The Efficacy And Safety Of Aclidinium/formoterol Fixed-Dose Combination Compared With Salmeterol/fluticasone In Patients With COPD: Results From A Phase Iii Study
    Vogelmeier, C.
    Paggiaro, P.
    Dorca, J.
    Sliwinski, P.
    Mallet, M.
    Kirsten, A. -M.
    Seoane, B.
    Segarra, R.
    Leselbaum, A.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] Effect of aclidinium/formoterol fixed-dose combinations on respiratory symptoms in COPD patients
    Jones, Paul
    D'Urzo, Anthony
    Rennard, Stephen
    Molins, Eduard
    Mergel, Victor
    Caracta, Cynthia
    Leselbaum, Anne
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [37] Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update
    D'Urzo, Anthony D.
    Singh, Dave
    Donohue, James F.
    Chapman, Kenneth R.
    Wise, Robert A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (09) : 1093 - 1106
  • [38] Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease
    Cazzola, Mario
    Rogliani, Paola
    Matera, Maria Gabriella
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (06) : 775 - 781
  • [39] Aclidinium/formoterol Fixed-Dose Combination Improves Bronchodilation And Is Well Tolerated In Patients With COPD: Results From The Acliform/COPD Study
    Singh, D.
    Jones, P. W.
    Bateman, E. D.
    Korn, S.
    Serra, C.
    Molins, E.
    Caracta, C.
    Leselbaum, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [40] Cardiovascular (CV) safety of aclidinium bromide/formoterol fumarate fixed dose combination (FDC) in COPD: Pooled analyses of three Phase III studies
    Donohue, James F.
    Bateman, Eric D.
    D'Urzo, Anthony
    Shrestha, Pomy
    Leselbaum, Anne
    Lei, Alejhandra
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345